Republic of the Philippines

NUEVA ECIJA UNIVERSITY OF SCIENCE AND

DRUG NAME MECHANISM OF INDICATIONS CONTRAINDICATIONS ADVERSE REACTIONS NURSING
Cabanatuan City, ACTION
Nueva Ecija, Philippines RESPONSIBILITIES
ISO 9001:2015
Generic name CERTIFIED
It contains strong betal- and O
 FFICE
Acute  V
OF THE ICE-PRESIDENT FOR
Hyper sensitivity
ACADEMIC
 Pain, burning,
ABefore
FFAIRS
alpha-adrenergic effects and
Norepinephrine moderate beta2 effects,
Hypotension  Patients who are hypotensive irritation,
Check for 12 rights when
from blood volume deficits discoloration, or skin
which increase cardiac changes where the administering medications.
except as an emergency
output and heart rate, injection was given;
measure to maintain coronary
decrease renal perfusion and  Cardiac
Branded name PVR, and cause variable BP
and cerebral artery perfusion  Sudden numbness, Double check all concentrations
Arrest until blood volume weakness, or cold
effects. Norepinephrine can with additional nurse
Levarterenol replacement therapy can be feeling anywhere in
also increase blood pressure
completed your body;
successfully in patients who
remain hypotensive  Concomitant use with some  Slow or uneven heart
following dopamine general anesthetics rate; During
Classification: cyclopropane (not available  Blue lips or finger
in the US), halothane (not nails, mottled skin; Monitor blood pressure and
Alpha/Beta
available in the US) apical pulse continously during
Adrenergic Agonists  Little or no urination;
Therapeutic:  Trouble breathing; norepinephrine therapy.
Vasopressor
 Problems with vision,
speech, or balance; or
 Severe headache, Cardiac monitor should be used
Dosage blurred vision, on patients receiving
pounding in your norepinephrine IV infusions.
neck or ears.

0.01-3.3
mcg/kg/min IV After
infusion
Assess patient frequently for
headache, chest pain, or other
signs of toxicity and adverse
Route effects
IV

Monitor BP continuously if
possible or every couple of
minutes

Transforming Communities through Science and Monitor EKG Email:

and CVP if
vpaa@neust.edu.ph
Technology possible www.neust.edu.ph
 Republic of the Philippines
NUEVA ECIJA UNIVERSITY OF SCIENCE AND

Cabanatuan City, Nueva Ecija, Philippines

ISO 9001:2015 CERTIFIED OFFICE OF THE VICE-PRESIDENT FOR ACADEMIC AFFAIRS
DRUG NAME MECHANISM OF INDICATIONS CONTRAINDICATIONS ADVERSE REACTIONS NURSING
ACTION RESPONSIBILITIES
Generic name Dobutamine directly Short-term Hypersensitivity to dobutamine or Headache, Increased heart Before
stimulates beta-1 treatment of bisulfites; Idiopathic hypertrophic rate, premature ventricular
Dobutamine subaortic stenosis. Acute contractions, angina, pain, Check for 12 rights when
receptors of the heart to adults with
myocardial infarction palpitations, shortness of administering medications.
increase myocardial cardiac
contractility and stroke decompensation breath, nausea
Branded name volume, resulting in Double check all concentrations
Dobutrex increased cardiac output. with additional nurse

Classification: Assess blood pressure (BP) and

Cardiac stimulant compare to normal values

Dosage During

Injection Assess urine flow, cardiac

(Dobutrex): 2.5 to output, pulmonary wedge
10 mcg/kg/min IV pressure, ECG, and BP closely
infusion during infusion.

Route After
IV infusion -Assess signs and symptoms of
CHF to help document whether
drug therapy is effective in
reducing these symptoms.

Transforming Communities through Science and Email: vpaa@neust.edu.ph

Technology www.neust.edu.ph
 Republic of the Philippines
NUEVA ECIJA UNIVERSITY OF SCIENCE AND

Cabanatuan City, Nueva Ecija, Philippines

ISO 9001:2015 CERTIFIED OFFICE OF THE VICE-PRESIDENT FOR ACADEMIC AFFAIRS

-Monitor signs of
hypersensitivity reactions,
including pulmonary symptoms,
or skin reaction.
-Notify physician or nursing
staff immediately if these
reactions occur

-Advise patient to inform nurse

immediately if chest pain;
dyspnea; or numbness, tingling
or burning of extremities

-Consult physician for

parameters for pulse, BP, or
ECG changes for adjusting dose
or discontinuing medication.

Transforming Communities through Science and Email: vpaa@neust.edu.ph

Technology www.neust.edu.ph